We recommend the adoption of the criteria for dementia proposed by the NIA/AA working group in 2011. * We recommend the adoption of the criteria concerning probable and possible Alzheimer's Disease dementia proposed by the NIA/AA working group in 2011. * We recommend the adoption of the criteria for MCI due to AD proposed by the NIA-AA working group in 2011. * We recommend reassessment of the utility of the concept of prodromal AD in the future when biomarkers are available, validated, and ready for use in Canada. * We recommend the IWG definition of asymptomatic at-risk for AD only for research purposes. * Given that the presence of brain amyloid in normal people is of uncertain significance, we discourage the use of amyloid imaging in individuals without memory loss, outside of the research setting. The medical community should be clear in its discussions with patients, the media and the general population that the presence of brain amyloid in normal people is of unclear significance at the present time. * We recommend the 2011 ASA/AHA recommendations for the diagnosis of VCI.
No takes yet. Share an insight, caveat, or question.
Gauthier et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: